- Integration of a new central utility plant in the existing building that is capable of servicing the new campus
- Installation of three 1,000-ton high-efficiency chillers and supporting infrastructure
- Five new substations to serve both the new clean room and existing building
Insulet Corporation, the leader in tubeless insulin pump technology (Omnipods), acquired a property in Acton, MA to serve as its sole U.S.-based manufacturing location. The new facility provides capacity for Insulet to manufacture up to 70% more Omnipods on a single line with up to 90% fewer personnel than its four locations based in China. The existing 201,690 sq. ft., three-story building was converted to a high-end corporate and manufacturing campus featuring space for research and development, post-market research and quality control operations, a call center, an employee fitness center with locker rooms, a cafeteria and commercial kitchen as well as open offices, conference rooms and executive suites. The 155,252 sq. ft. addition, provides clean room manufacturing and warehouse space, quarantine inspection and receiving areas, a gowning and wash unit, packaging rooms and a shipping/receiving area.
As part of the addition, Consigli installed three 1,000 ton water-cooled centrifugal high-efficiency chillers, as well as the associated pumps and cooling towers. This scope required a phased demolition and installation of the new cooling and heating equipment. As part of the building’s addition, Consigli also managed the installation of five new substations—four to serve the new clean room and one to serve the existing building.